您当前的位置:
首页 >
文章列表页 >
Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial
RESEARCH | 更新时间:2023-09-05
    • Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial

    • Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial

    • Ming-Huan Zhu ,Zhen-Jing Liu ,Qiong-Yue Hu ,Jia-Yu Yang ,Ying Jin ,Na Zhu ,Ying Huang ,Dian-Hong Shi ,Min-Jia Liu ,Hong-Yang Tan ,Lei Zhao ,Qin-Yu Lv ,Zheng-Hui Yi ,Feng-Chun Wu ,Ze-Zhi Li
    • MMR 2023年10卷第4期 页码:431-443
    • DOI: 10.1186/s40779-022-00420-0     

      中图分类号:

    移动端阅览

  •  
  •  
  • HTML全文

  • 图( 4 ) 表( 3 )

  • 参考文献

  • 出版信息

  • 数据统计

论文导航
icon
试读结束,您可以激活您的VIP账号继续阅读。
去激活 >
icon
试读结束,您可以通过登录账户,到个人中心,购买VIP会员阅读全文。
已是VIP会员?
去登录 >

51

浏览量

15

下载量

0

CSCD

文章被引用时,请邮件提醒。
提交
工具集
  • BibTeX下载
  • Endnote下载
  • RefMan 下载
  • NoteExpress下载
  • NoteFirst下载

相关文章

Prediction of treatment response to antipsychotic drugs for precision medicine approach to schizophrenia: randomized trials and multiomics analysis
Prediction of treatment response to antipsychotic drugs for precision medicine approach to schizophrenia: randomized trials and multiomics analysis
Metabolic syndrome and risk of sepsis and sepsis-related mortality: evidence from two large prospective cohort studies
Engineered exosomes for diabetic foot ulcers: lessons learned, challenges remain
Engineering of functional auditory neurons from human induced pluripotent stem cells

相关作者

Zhe-Wei Kang
Yun-Dan Liao
Jun Li
Tian-Lan Lu
Hao Yan
Xiao Xiao
Yong-Feng Yang
Wen-Qiang Li

相关机构

Institute of Mental Health, Peking University Sixth Hospital
Chinese Institute for Brain Research
National Clinical Research Center for Mental Disorders, Peking University Sixth Hospital
NHC Key Laboratory of Mental Health and Research Unit of Diagnosis and Treatment of Mood Cognitive Disorder (2018RU006), Chinese Academy of Medical Sciences
Peking University Huilongguan Clinical Medical School, Beijing Huilongguan Hospital